Literature DB >> 12634314

Rapid proliferation of prostatic epithelial cells in spontaneously hypertensive rats: a model of spontaneous hypertension and prostate hyperplasia.

Ariella Matityahou1, Nurit Rosenzweig, Eliahu Golomb.   

Abstract

Spontaneously hypertensive rats (SHRs), a commonly used model of genetic hypertension, exhibit features of glandular hyperplasia of the ventral prostate, including the narrowing of acini with epithelial protrusions into the lumen and the piling up of epithelial cells. These rats also have frequent urinary voiding. In order to define the fundamental processes that lead to prostatic hyperplasia in SHRs, we compared the proliferation rate of their prostatic epithelial cells (PECs) in primary culture and in vivo to that of Wistar-Kyoto rats (WKYs), their normotensive controls. In vitro, primary cultures of SHR PECs had a shorter doubling time than those of WKY (3.3 vs 8.0 days) and showed higher levels of bromodeoxyuridine (BrdU) incorporation into DNA. In vivo, the BrdU incorporation seen 48 hours following injection was observed primarily in areas of epithelial piling up, which are seen in SHRs but not in WKYs. We concluded that prostate hyperplasia in SHRs results from a genuine increase in the proliferation rate of PECs and that this rapid proliferation is a fundamental feature of SHR PECs, maintained both in vivo and in vitro. Thus, SHRs can serve as a model for glandular hyperplasia of the prostate, resulting from a genetic tendency for an increased rate of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634314     DOI: 10.1002/j.1939-4640.2003.tb02671.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  6 in total

Review 1.  Animal models of benign prostatic hyperplasia.

Authors:  Junjie Zhang; Mengda Zhang; Jin Tang; Guangming Yin; Zhi Long; Leye He; Chuanchi Zhou; Lufeng Luo; Lin Qi; Long Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-09-01       Impact factor: 5.554

2.  Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.

Authors:  Firas Abdollah; Alberto Briganti; Nazareno Suardi; Fabio Castiglione; Andrea Gallina; Umberto Capitanio; Francesco Montorsi
Journal:  Korean J Urol       Date:  2011-08-22

3.  Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type A injection.

Authors:  Tiago Gorgal; Ana Charrua; João F Silva; António Avelino; Paulo Dinis; Francisco Cruz
Journal:  BMC Urol       Date:  2012-01-04       Impact factor: 2.264

4.  Prostate enlargement and altered urinary function are part of the aging process.

Authors:  Teresa T Liu; Samuel Thomas; Dalton T Mclean; Alejandro Roldan-Alzate; Diego Hernando; Emily A Ricke; William A Ricke
Journal:  Aging (Albany NY)       Date:  2019-05-13       Impact factor: 5.682

5.  Terazosin treatment induces caspase-3 expression in the rat ventral prostate.

Authors:  Georgios Papadopoulos; Dimitrios Vlachodimitropoulos; Aspasia Kyroudi; Mirsini Kouloukoussa; Despina Perrea; Dionisios Mitropoulos
Journal:  J Clin Med Res       Date:  2013-02-25

Review 6.  Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension?

Authors:  Wolfgang Kopp
Journal:  Nutr Metab Insights       Date:  2018-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.